McNEIL-PPC, Inc. and its affiliate McNeil MMP, LLC have completed the acquisition of full ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. joint venture in the U.S. from Merck Sharp & Dohme Corp. The joint venture will be renamed McNeil Consumer Pharmaceuticals Co. and will continue to market products under the Pepcid, Mylanta, and Mylicon brands. In addition, Johnson & Johnson Inc., through its McNeil Consumer Healthcare Division, has acquired from Merck Canada...